Literature DB >> 16684936

An overview of psychiatric issues in liver disease for the consultation-liaison psychiatrist.

Catherine C Crone1, Geoffrey M Gabriel, Andrea DiMartini.   

Abstract

Liver disease is a common cause of morbidity and mortality in the United States and elsewhere. Arising from infectious, hereditary, or toxin-induced sources, the detection of liver disease often requires a high index of suspicion. Clinical presentations are highly variable and are often accompanied by neuropsychiatric symptoms. This fact, along with an increased incidence of liver disease among patients with primary psychiatric disorders and the presence of varied drug use, complicates the tasks of providing care to patients with liver disease. To assist the consultation-liaison psychiatrist, the authors present the first of a two-part series focused on psychiatric issues in liver disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16684936     DOI: 10.1176/appi.psy.47.3.188

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  5 in total

1.  Psychiatric Disorders and their Association with Liver Transplant Outcome In Iran.

Authors:  A Sahraian; M Sharifian; B Geramizadeh; S A Malek-Hosseini
Journal:  Int J Organ Transplant Med       Date:  2014

2.  Management of Alcohol Use Disorder in Patients Requiring Liver Transplant.

Authors:  Mary R Lee; Lorenzo Leggio
Journal:  Am J Psychiatry       Date:  2015-12       Impact factor: 18.112

Review 3.  Pharmacokinetic changes of psychotropic drugs in patients with liver disease: implications for dose adaptation.

Authors:  Chantal Schlatter; Sabin S Egger; Lydia Tchambaz; Stephan Krähenbühl
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 4.  Psychotropic drugs and liver disease: A critical review of pharmacokinetics and liver toxicity.

Authors:  Diogo Telles-Correia; António Barbosa; Helena Cortez-Pinto; Carlos Campos; Nuno B F Rocha; Sérgio Machado
Journal:  World J Gastrointest Pharmacol Ther       Date:  2017-02-06

5.  A comprehensive gene-centric pleiotropic association analysis for 14 psychiatric disorders with GWAS summary statistics.

Authors:  Haojie Lu; Jiahao Qiao; Zhonghe Shao; Ting Wang; Shuiping Huang; Ping Zeng
Journal:  BMC Med       Date:  2021-12-13       Impact factor: 8.775

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.